Qian Jiang

Member of the Ocular Oncology and Oculoplastic Surgery Group of the Chinese Medical Association, Head of the Orbital Disease and Ocular Oncology Group of the Ophthalmology Branch of the Shanghai Medical Association, Executive Committee Member of the Asia-Pacific Society of Oculoplastic Surgery, Member of the American Academy of Oculoplastic Surgery, and Deputy Head of the Retinoblastoma Group of the Ophthalmology Branch of the Cross-Strait Medical and Health Exchange Association. Served as a member of the 7th to 10th Committees of the Ophthalmology Branch of the Shanghai Medical Association from 2006 to 2015. He pioneered eye-preserving treatment for retinoblastoma in China, achieving a long-term survival rate of over 95% for children with the disease; he was the only doctor in China to perform heavy carbon ion therapy for choroidal melanoma. He pioneered the "Stone Coffin Sealing" three-step therapy for malignant dacryocystorhinostomy tumors, essentially eliminating the risk of postoperative cervical lymph node metastasis; and he was the first in the world to propose a "tumor shrinkage + decompression" scheme for orbital apex vascular malformations, reducing the risk of postoperative visual loss in this highly blinding eye disease to below 2%. With 30 years of professional experience, he has had no medical malpractice cases, published 141 original papers, and presided over 8 research projects. He specializes in the diagnosis and treatment of various complex ophthalmic conditions, such as ocular tumors, orbital tumors, eyelid tumors, Graves' ophthalmopathy, Graves' ophthalmopathy, orbital inflammation, and orbital fractures. He was nominated for the Shanghai Silver Snake Award.